Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy Study of Endothelial Progenitor Cell Capture Stent With 1 Months Dual Antiplatelet Therapy (INNOVATION)

This study has been terminated.
(Previous other study including EPC capture stent raised the issue of safety (significant high incidence of instent restenosis))
Sponsor:
Collaborators:
OrbusNeich
Yuhan Corporation
Information provided by (Responsible Party):
Seung-Hwan Lee, Yonsei University
ClinicalTrials.gov Identifier:
NCT01394848
First received: July 11, 2011
Last updated: December 3, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2013
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)